Huahai Pharmaceutical provides ¥205m guarantee for wholly-owned subsidiary
Zhejiang Huahai Pharmaceutical Co., Ltd. announced it has provided a maximum guarantee of ¥205,000,000 to its wholly-owned subsidiary, Zhejiang Huahai Jiancheng Pharmaceutical Co., Ltd. This guarantee, for bank credit facilities, was approved by the company's board of directors on August 25, 2025, and subsequently implemented on October 14, 2025, through a guarantee contract with Industrial and Commercial Bank of China, Linhai Branch.
As of the disclosure date, the company's total actual guarantee balance for Huahai Jiancheng, excluding the current guarantee, stands at ¥495,000,000. The guarantee is a joint and several liability with a term of three years from the maturity date of the principal contract, deemed necessary to meet Huahai Jiancheng's business development and construction capital requirements.
The total external guarantee amount by the company and its subsidiaries, including this transaction, is ¥3,572,228,300. This represents 40.15% of the company's net assets attributable to shareholders as of the latest audited period. All guarantees are for subsidiaries or associate companies, with no overdue guarantees reported.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Zhejiang Huahai Pharmaceutical publishes news
Free account required • Unsubscribe anytime